Cullen/Frost Bankers, Inc. / ABBV
Cullen/Frost Bankers, Inc.’s Abbvie Inc Position
Does Cullen/Frost Bankers, Inc. own Abbvie Inc (ABBV)? Yes — 358.3K shares worth $78M (+0.89% of its 13F portfolio) as of Q1 2026, down from 365.5K shares the prior filed quarter.
Position Value
$78M
Q1 2026
Shares
358.3K
% of Portfolio
+0.89%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 358.3K | $78M | +0.89% |
| Q4 2025 | 365.5K | $84M | +0.92% |
| Q3 2025 | 382.2K | $88M | +1.03% |
| Q2 2025 | 396.2K | $74M | +0.92% |
| Q1 2025 | 384.5K | $81M | +1.13% |
| Q4 2024 | 380.9K | $68M | +0.93% |
| Q3 2024 | 402.1K | $79M | +1.08% |
| Q2 2024 | 397.8K | $68M | +0.99% |
| Q1 2024 | 367.6K | $67M | +0.99% |
| Q4 2023 | 359.7K | $56M | +0.88% |
| Q3 2023 | 324.7K | $48M | +0.84% |
| Q2 2023 | 322.5K | $43M | +0.74% |
| Q1 2023 | 326.8K | $52M | +0.95% |
| Q4 2022 | 315.1K | $51M | +0.97% |
| Q3 2022 | 289.6K | $39M | +0.89% |
| Q2 2022 | 242.8K | $37M | +0.83% |
| Q1 2022 | 243.0K | $39M | +0.77% |
| Q4 2021 | 239.6K | $32M | +0.62% |
| Q3 2021 | 246.9K | $27M | +0.54% |
| Q2 2021 | 249.8K | $28M | +0.57% |
| Q1 2021 | 251.0K | $27M | +0.60% |
| Q4 2020 | 255.8K | $27M | +0.63% |
| Q3 2020 | 296.9K | $26M | +0.65% |
| Q2 2020 | 487.0K | $48M | +1.26% |
| Q1 2020 | 450.3K | $34M | +1.19% |
| Q4 2019 | 446.4K | $40M | +1.08% |
| Q3 2019 | 431.2K | $33M | +0.97% |
| Q2 2019 | 411.8K | $30M | +0.93% |
| Q1 2019 | 413.5K | $33M | +1.02% |
| Q4 2018 | 359.4K | $33M | +1.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cullen/Frost Bankers, Inc.’s full portfolio or all institutional holders of ABBV.